Last Price$33.90.6%
Market Cap$15.2B
N/A
Industry median - 4.9x
5Y Historical average - 10.4x
(0.3x)
Industry median - 1.2x
5Y Historical average - 4.1x
FCF to Interest
12.3x
Industry median - (8.8x)
5Y Historical average - 12.0x
0.0%
Industry median - 3.5%
5Y Historical average - 62.1%
RPRX Health Rating
RPRX Health rating
5.1
RPRX Health rating performance
RPRX Financial Stability & Strength
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
FCF to Interest
Intangibles as % of Total Assets
Competing with RPRX Financial Health
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Net Debt | Health score | Current ratio | Quick ratio | Net Debt to FCF | FCF to Interest | Intangibles as % of Total Assets | Total Debt to Equity |
$15.2B | ($929.0M) | 5.1 | N/A | N/A | (0.3x) | 12.3x | 0.0% | 0.0% | |
$402.0B | DKK 76.5B | 5.9 | 0.7x | 0.5x | 1.1x | 15.7x | 19.5% | 71.6% | |
$125.5B | ($4,366.4M) | 5.8 | 2.7x | 2.2x | 5.5x | (25.8x) | 3.7% | 10.7% | |
$74.0B | ($15.9B) | 6.9 | 33.5x | 29.7x | (4.4x) | 105.2x | 3.0% | 5.7% | |
$38.1B | N/A | 5.6 | N/A | N/A | N/A | (103.5x) | N/A | N/A | |
$31.3B | ($1,398.5M) | 6.8 | 2.8x | 2.6x | 32.8x | (0.3x) | 0.0% | 1,931.9% | |
$27.1B | (€16.5B) | 6.2 | 7.3x | 7.1x | (16.7x) | 25.3x | 3.9% | 1.3% | |
$14.8B | ($2,114.5M) | 5.3 | 2.0x | 1.8x | (9.0x) | 103.1x | 2.1% | 1.3% | |
$14.6B | ($405.1M) | 6.8 | 10.2x | 9.9x | 2.9x | (16.4x) | 0.0% | 1.9% | |
$14.0B | ($2,967.0M) | 6.9 | 5.2x | 4.8x | (2.7x) | 25.2x | 1.1% | 4.7% | |
$1,846.9M | ($1,600.5M) | 5.1 | 1.9x | 1.6x | 1.6x | (113.8x) | 0.9% | 32.1% |
FAQ
What is the Royalty Pharma plc (RPRX) quick ratio?
The Royalty Pharma plc (RPRX) quick ratio is N/A, compared to the industry median of 4.9x and the 5-year historical average of 10.4x.
What is the Royalty Pharma plc (RPRX) net debt to Free Cash Flow (FCF) ratio?
The Royalty Pharma plc (RPRX) net debt to FCF ratio is (0.3x), compared to the industry median of 1.2x and the 5-year historical average of (4.1x).
What is Royalty Pharma plc (RPRX) Free Cash Flow (FCF) to interest ratio?
Royalty Pharma plc (RPRX) FCF to interest ratio is 12.3x, compared to the industry median of (8.8x) and the 5-year historical average of 12.0x.
What is the Royalty Pharma plc (RPRX) total debt to equity ratio?
The Royalty Pharma plc (RPRX) total debt to equity ratio is 0.0%, compared to the industry median of 3.5% and the 5-year historical average of 62.1%.